Related Experiment Video
Updated: Jan 4, 2026
10:24
In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
Published on: June 11, 2015
11.2K
Aspirin Effect on Staphylococcus aureus-Platelet Interactions During Infectious Endocarditis
Nadji Hannachi1, Gilbert Habib1,2, Laurence Camoin-Jau1,3
1Aix Marseille Univ, IRD, APHM, MEPHI, IHU Méditerranée Infection, Marseille, France.
Frontiers in Medicine
|November 5, 2019
Summary
Aspirin
Area of Science:
- Cardiology
- Infectious Diseases
- Hematology
Background:
- Infectious endocarditis (IE) is a severe condition with high mortality.
- Staphylococcus aureus is now the leading cause of IE.
- Embolic events are a major complication of IE, despite advances in treatment.
Purpose of the Study:
- To review the role of aspirin in Staphylococcus aureus infectious endocarditis.
- To examine aspirin's impact on vegetation formation and embolic events.
- To assess aspirin's influence on platelet-bacteria interactions in IE.
Main Methods:
- Literature review of in vitro, experimental, and clinical studies.
- Focus on studies investigating aspirin's effect on S. aureus IE.
- Analysis of data concerning vegetation genesis, embolic, and hemorrhagic events.
Main Results:
- Conflicting results exist regarding aspirin's efficacy in IE.
- Aspirin's influence on platelet-S. aureus interaction is a key area of investigation.
- Further research is needed to clarify aspirin's role in managing IE complications.
Conclusions:
- The role of aspirin in infectious endocarditis, particularly S. aureus IE, requires further clarification.
- Understanding aspirin's effect on platelet-bacteria interactions is crucial for managing embolic events.
- Evidence is mixed, necessitating careful consideration of aspirin use in IE patients.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.0K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K
01:25Endocarditis I: Introduction
349
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
349
01:22Formation of the Platelet Plug
8.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.5K
01:25Endocarditis II: Clinical Features of Infective Endocarditis
347
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
347
01:18Endocarditis III: Medical Management
187
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
187
01:29Endocarditis IV: Nursing Management
285
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
285